Find Meglumine Antimonate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Meglumine antimonate, Meglumine antimoniate, N-methylglucamine antimonate, 133-51-7, Methylglucamine antimonate, Protostib
Molecular Formula
C7H18NO8Sb
Molecular Weight
365.98  g/mol
InChI Key
XOGYVDXPYVPAAQ-SESJOKTNSA-M
FDA UNII
75G4TW236W

Meglumine Antimonate
ANTIMONY salt of meglumine that is used in the treatment of LEISHMANIASIS.
1 2D Structure

Meglumine Antimonate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
hydroxy(dioxo)-5-stibane;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
2.1.2 InChI
InChI=1S/C7H17NO5.H2O.2O.Sb/c1-8-2-4(10)6(12)7(13)5(11)3-9;;;;/h4-13H,2-3H2,1H3;1H2;;;/q;;;;+1/p-1/t4-,5+,6+,7+;;;;/m0..../s1
2.1.3 InChI Key
XOGYVDXPYVPAAQ-SESJOKTNSA-M
2.1.4 Canonical SMILES
CNCC(C(C(C(CO)O)O)O)O.O[Sb](=O)=O
2.1.5 Isomeric SMILES
CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.O[Sb](=O)=O
2.2 Other Identifiers
2.2.1 UNII
75G4TW236W
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Meglumine Antimoniate

2. N Methylglucamine Antimonate

3. N-methylglucamine Antimonate

2.3.2 Depositor-Supplied Synonyms

1. Meglumine Antimonate

2. Meglumine Antimoniate

3. N-methylglucamine Antimonate

4. 133-51-7

5. Methylglucamine Antimonate

6. Protostib

7. 75g4tw236w

8. N-methyl Glucamine Antimoniate

9. 2168-rp

10. Einecs 205-108-3

11. Glucantim

12. Unii-75g4tw236w

13. 1-deoxy-1-(methylamino)glucitol Antimonate(v)

14. 1-deoxy-1-(methylamino)-d-glucitol, Compound With Antimonic Acid (1:1)

15. D-glucitol, 1-deoxy-1-(methylamino)-, Compd. With Antimonic Acid (1:1)

16. Glucitol, 1-deoxy-1-(methylamino)-, Compd. With Antimonic Acid (1:1), D-

17. Schembl146372

18. Dtxsid4043935

19. D-glucitol, 1-deoxy-1-(methylamino)-, Trioxoantimonate(1-)

20. Mfcd01725422

21. Meglumine Antimonate [who-dd]

22. Akos025310684

23. Db13732

24. N-methylglucamine Antimonate [mi]

25. 133m517

26. Q2757969

27. (2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentaol Stibenate

28. D-glucitol, 1-deoxy-1-(methylamino)-, Compd. With Antimonic Acid (hsbo3) (1:1)

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 365.98 g/mol
Molecular Formula C7H18NO8Sb
Hydrogen Bond Donor Count7
Hydrogen Bond Acceptor Count9
Rotatable Bond Count6
Exact Mass365.00705 g/mol
Monoisotopic Mass365.00705 g/mol
Topological Polar Surface Area168 Ų
Heavy Atom Count17
Formal Charge0
Complexity180
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antiprotozoal Agents

Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)


4.2 ATC Code

P - Antiparasitic products, insecticides and repellents

P01 - Antiprotozoals

P01C - Agents against leishmaniasis and trypanosomiasis

P01CB - Antimony compounds

P01CB01 - Meglumine antimonate


FDF Dossiers

read-more
read-more

01

PRG Pharma

India
ASC 2024
Not Confirmed
arrow

PRG Pharma

India
arrow
ASC 2024
Not Confirmed

meglumine antimoniate

Brand Name :

Dosage Form : Injection

Dosage Strength : 5ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty